ArticleBlood2013

Src-kinase inhibitors sensitize human cells of myeloid origin to Toll-like-receptor-induced interleukin 12 synthesis.

Matthias Wölfl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.